King, LA. New phenethylamines in Europe Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
Błachut, D; Czarnocki, Z; Wojtasiewicz, K. α-Phenylethylamine in illegally produced amphetamine Forensic Sci. Int., 1 Dec 2001, 123 (2–3), 182–190. 171 kB. https://doi.org/10.1016/S0379-0738(01)00548-5 #I MS,NMR,IR
Ottaviano, V; Furnari, C; Rosati, F. Identification of di(β-phenylisopropyl)amine as the main ingredient in illicit amphetamine tablets Ann. Ist. Super. Sanità, , 38 (3), 331–335. 125 kB. #di(β-phenylisopropyl)amine GC,MS,NMR
EMCDDA. New drugs in Europe, 2005, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2006. 1.2 MB. #DPIA
Coumbaros, JC; Kirkbride, KP; Klass, G. Application of solid-phase microextraction to the profiling of an illicit drug: Manufacturing impurities in illicit 4-methoxyamphetamine J. Forensic Sci., 1 Nov 1999, 44 (6), 1237–1242. 547 kB. https://doi.org/10.1520/JFS14594J #10 LC,MS,other
King, LA. Designer drugs related to amphetamine (1990–1996) JCLIC, 1 Jul 1996, 6 (3), 15-16. 562 kB. #15
Huizer, H; Brussee, H; Poortman-van der Meer, A. Di-(β-Phenylisopropyl)amine in Illicit Amphetamine J. Forensic Sci., 1 Apr 1985, 30 (2), 427–438. 419 kB. https://doi.org/10.1520/JFS11822J #DPIA GC,MS,NMR,IR,TLC
Forbes, IJ; Kirkbride, KP. The origin of alkenes in illicit amphetamine: An examination of the illicit synthesis of phenyl-2-propanone J. Forensic Sci., 1 Sep 1992, 37 (5), 1311–1318. 353 kB. https://doi.org/10.1520/JFS13318J #11 GC,MS
Kram, TC. Reidentification of a major impurity in illicit amphetamine J. Forensic Sci., 1 Jul 1979, 24 (3), 596–599. 282 kB. https://doi.org/10.1520/JFS10875J #III-2 MS,NMR,IR
Kram, TC; Kruegel, AV. The identification of impurities in illicit methamphetamine exhibits by gas chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy J. Forensic Sci., 1 Jan 1977, 22 (1), 40–52. 444 kB. https://doi.org/10.1520/JFS10366J #XIII GC,MS,NMR
Kolaczynska, KE; Ducret, P; Trachsel, D; Hoener, MC; Liechti, ME; Luethi, D. Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA Eur. Neuropsychopharmacol., 1 Jun 2022, 59, 9–22. 1.5 MB. https://doi.org/10.1016/j.euroneuro.2022.03.006 #DPIA